The Respiratory Disease

Triple versus Dual Inhaler Therapy in Patients with COPD - IMPACT Trial can change COPD Guidelines in 2019

Emerging biological therapies for treating eosinophilic COPD

Exacerbations of COPD: prevention is still actual in 2018!!

Dual LABA/LAMA bronchodilators in COPD: why? when? and how?

COPD in 2018: syndrome or disease - first steps to new classification

Pulmonary rehabilitation and cardiovascular risk in COPD: a systematic review (Free Full text from 2017 COPD Research and Practice)

Adherence to COPD treatment: Myth and reality (article from 2017 Respiratory Medicine)

Ashtma-Chronic obstructive pulmonary disease overlap syndrome (ACOS): current evidence and future research directions (Free Full text from 2017 COPD Research and Practice)

GOLD 2017 recommendations for COPD patients: toward a more personalized approach (Free full text from COPD Research and Practice)

ERS Guidelines 2017: exhaled biomarkers in lung disease

Triple therapy versus LAMA therapy for COPD - TRINITY study (Lancet 2017 article)

News alert: According to the last Pharma R&D 2017 Review, Respiratory Drugs the only group decreasing

Management of COPD in Patients with Cardiovascular Diseases (Hot Topic Review from Drugs 2017)

Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 2017 (Free full text)

The impact of anaemia and iron deficiency in COPD: A clinical overview (free full text from 2017 Revista Portuguesa de Pneumologia)

Chronic obstructive pulmonary disease and diabetes (free full text from COPD Research and Practice)

LAMA plus LABA versus LABA plus ICS for stable COPD (free full text from The Cochrane Library)